Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
about
Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line.Circumventing tumor resistance to chemotherapy by nanotechnologyAcquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenograftsIn vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexesCellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents.Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum (II).Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex.Anti-proliferative activity and mechanism of action of titanocene dichloride.In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin.An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells.Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatinBCL-2 family protein expression and platinum drug resistance in ovarian carcinomaDOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancerThe cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.Genomic imbalances associated with acquired resistance to platinum analogues.Cellular accumulation of the anticancer agent cisplatin: a review.Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes.Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivo.
P2860
Q30823476-0B6F3D0B-6299-4ABF-917C-293B0262BCDEQ34618357-4F8849F4-26D2-4DBB-918C-3F32F4E22B4AQ35975934-21F27DC4-9C0C-48AC-A7C9-154FCA837BB4Q35977240-602E32C1-5952-4AAA-B6F1-55F7787B0E49Q35994695-996D74CA-BAF1-4A43-9D16-902C03FA06ADQ36079502-28F1217D-BBEC-4068-AD84-A3E6E795640AQ36079602-1CADB73E-F3E0-4AAE-9BDD-F04A94CB27EFQ36114681-A1D85F1F-14BF-46C6-A8B1-52A4FAAB3A24Q36134626-A1DFB03F-A43D-49B2-ADC7-9A5E629F16D3Q36135855-4FBF9802-4EE2-42F4-A86B-BBFF1B733FD4Q36141013-0A5825A6-AA00-49E4-9AE5-B327045455BDQ36292954-73D527E0-83A6-4D70-A0C5-BE2BAAB448AEQ36295090-9287D1E9-8C09-4185-A18E-82AD5D19AA0FQ36430906-5D0D8811-7387-4CDC-9225-B3A10F0B60B5Q36566743-FC589BE0-EFEE-4F41-9453-D0ABEC37CDB1Q36619998-ADB8FB9A-5D77-4BF2-8F05-891927D83A06Q36621123-4774BB4E-AC84-42AA-A3A7-02CD57C0D124Q37276254-F1C9CB9B-2F2A-46DB-81F1-364D72EEF248Q40001235-E50BCCFD-9603-4DD3-A8A3-C313F1D67E1FQ40807070-7D67EA7A-1FEA-4DC6-BA33-BF3707FC40F6Q40917698-9E74A6EC-A093-44FF-9A0A-0B12EA17A270Q41394938-7ACDE41D-317C-4BDB-91E3-1DA763A4C0F3Q42351657-FCDD5863-D48A-45D8-ABB3-30A0C1A3B439Q42590267-42F21610-1C4B-484F-BC00-9BE2AAAC0763
P2860
Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Mechanism-related circumventio ...... e platinum(IV) dicarboxylates.
@en
type
label
Mechanism-related circumventio ...... e platinum(IV) dicarboxylates.
@en
prefLabel
Mechanism-related circumventio ...... e platinum(IV) dicarboxylates.
@en
P2093
P4510
P1433
P1476
Mechanism-related circumventio ...... e platinum(IV) dicarboxylates.
@en
P2093
Kelland LR
O'Neill CF
P304
P407
P577
1992-07-01T00:00:00Z